Evidence map›Paper›PMID 19366847›Full record

ArticleThe Journal of clinical endocrinology and metabolism2009

Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.

Tamara Wexler, Lindsay Gunnell, Zehra Omer, Karen Kuhlthau, Catherine Beauregard, Gwenda Graham, Andrea L Utz, Beverly Biller, Lisa Nachtigall, Jay Loeffler and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00182091 (Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly), which is not on this map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00182091 nacompletednot on this map

Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly

TypeinterventionalSponsorMassachusetts General HospitalRan2004 to 2010Enrolled75ConditionsAcromegaly, Growth Hormone Deficiency, Pituitary DiseaseArmsRecombinant human growth hormone, Saline
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Anxiety, depression and acromegaly: a systematic review.Journal of endocrinological investigation · 2025
    Pooled it
  4. Pooled it
  5. Trial
  6. Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
    Trial
  7. Article
  8. Article
  9. Neuroendocrine Disruptions Following Head Injury.Current neurology and neuroscience reports · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2016
    Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tamara WexlerNeuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Lindsay Gunnell
Zehra Omer
Karen Kuhlthau
Catherine Beauregard
Gwenda Graham
Andrea L Utz
Beverly Biller
Lisa Nachtigall
Jay Loeffler
Brooke Swearingen
Anne Klibanski
Karen K Miller

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
NCRR NIH HHS UL1 RR025758PHS HHS M01 RB01066
6 · The paper itself

Abstract

contextBoth GH deficiency (GHD) and GH excess are associated with a decreased quality of life. However, it is unknown whether patients with GHD after treatment for acromegaly have a poorer quality of life than those with normal GH levels after cure of acromegaly.

objectiveThe aim of the study was to determine whether patients with GHD and prior acromegaly have a poorer quality of life than those with GH sufficiency after cure of acromegaly. DESIGN AND

settingWe conducted a cross-sectional study in a General Clinical Research Center. STUDY

participantsForty-five patients with prior acromegaly participated: 26 with GHD and 19 with GH sufficiency.

interventionThere were no interventions.

main outcome measuresWe evaluated quality of life, as measured by 1) the Quality of Life Adult Growth Hormone Deficiency Assessment (QoL-AGHDA); 2) the Short-Form Health Survey (SF-36); and 3) the Symptom Questionnaire.

resultsMean scores on all subscales of all questionnaires, except for the anger/hostility and anxiety subscales of the Symptom Questionnaire, showed significantly impaired quality of life in the GH-deficient group compared with the GH-sufficient group. Peak GH levels after GHRH-arginine stimulation levels were inversely associated with QoL-AGHDA scale scores (R = -0.53; P = 0.0005) and the Symptom Questionnaire Depression subscale scores (R = -0.35; P = 0.031) and positively associated with most SF-36 subscale scores.

conclusionsOur data are the first to demonstrate a reduced quality of life in patients who develop GHD after cure of acromegaly compared to those who are GH sufficient. Further studies are warranted to determine whether GH replacement would improve quality of life for patients with GHD after cure from acromegaly.

Indexed as

Quality of LifeAcromegalyAdultCross-Sectional StudiesEmotionsFemaleGrowth DisordersHuman Growth HormoneHumansInsulin-Like Growth Factor IMaleMental DisordersMiddle AgedSurveys and QuestionnairesHuman Growth HormoneInsulin-Like Growth Factor I

Identifiers

PMID19366847
PMCPMC2708960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.